4 results about "Angelicae sinensis extract" patented technology

The invention relates to the technical field of cosmetics, in particular to a nanoscale repair composition, a nanoscale repair cosmetic and a preparation method and application of the nanoscale repair composition and the nanoscale repair cosmetic. The invention discloses a nanoscale repairing composition. The traditional Chinese medicine composition is prepared from the following raw material components in parts by weight: 4 to 6 parts of herba centellae extract, 2 to 4 parts of chamomile extract, 2 to 4 parts of radix ginseng extract, 1 to 3 parts of rhizoma curcumae longae extract, 3 to 5 parts of aloe extract, 1 to 3 parts of oat extract, 1 to 2 parts of liquorice root extract, 0.3 to 0.7 part of green tea extract, 0.5 to 1.5 parts of radix salviae miltiorrhizae extract, 0.5 to 1.5 parts of radix angelicae sinensis extract and 0.5 to 1.5 parts of ganoderma atrum extract. , 0.5 to 1.5 parts of radix astragali seu hedysari extract, 0.3 to 0.7 part of rhizoma polygoni cuspidati extract, and 0.3 to 0.7 part of onion extract. The nanoscale repairing composition and the nanoscale repairing cosmetic disclosed by the invention can improve the moisture content of skin, reduce moisture loss and redness of the skin, accelerate healing of injured skin, effectively relieve inflammatory response and promote collagen regeneration of the skin.

The invention discloses an external preparation suitable for people with weakness of spleen and stomach and a preparation method thereof, the external preparation comprises a traditional Chinese medicine extract composite component, and the external preparation is prepared from the following raw materials in parts by weight: maguey leaf extract; a salvia miltiorrhiza root extract; a polygonum multiflorum root extract; a ginseng root extract; an angelica root extract; a zanthoxylum fruit extract; an astragalus membranaceus root extract; an abrus herb extract; a microcos paniculata extract; and striga asiatica extract. A microbial fermentation product comprising a Thermus thermophilus fermentation product; and Leuconostoc / radish root fermentation filtrate. The transdermal enhancer comprises a ginger extract, methyl nicotinate and a pepper extract. And the auxiliary materials comprise cyclopentasiloxane, squalane, inulin, and disteardimonium hectorite. Chinese herbal medicines are combined with a modern microbial fermentation technology, and based on a percutaneous delivery system, sub-health symptoms such as unsmooth defecation, abdominal distension, abdominal cold, abdominal fat accumulation, edema and poor complexion of people with weakness of the spleen and the stomach are improved.

The invention relates to an acupoint injection composition for treating pain and a preparation and application method thereof, and belongs to the technical field of health care medicines. The acupoint injection composition for treating pain is prepared from the following components in parts by weight: 10 to 30 parts of radix angelicae sinensis extract, 10 to 30 parts of radix ginseng extract, 10 to 30 parts of herba taraxaci extract, 5 to 20 parts of cortex eucommiae extract, 10 to 30 parts of folium artemisiae argyi extract, 5 to 20 parts of oyster extract, 10 to 30 parts of rhizoma gastrodiae extract and 5 to 10 parts of composite penetrant. Wherein the formula of the composite penetrating agent comprises the following components in parts by weight: 0.5-1 part of a clove extract, 0.5-2 parts of a pepper extract and 2-9 parts of a chemical penetration enhancer; the composition prepared by the invention has the characteristics of high permeability and pain treatment.

This application discloses the use of imperatorin angelica ester in the preparation of drugs for treating and / or preventing infections caused by intracellular bacteria, relating to the field of biomedical technology. The application includes administering an effective amount of imperatorin angelica ester to inhibit the survival of the intracellular bacteria within host macrophages. Imperatorin angelica ester specifically inhibits the survival and proliferation of intracellular bacteria (such as Mycobacterium tuberculosis, Mycobacterium abscessis, and Salmonella) within cells by modulating the immune function of host macrophages, such as enhancing their bactericidal activity or altering their intracellular microenvironment. This provides a new drug candidate and strategy for treating refractory intracellular bacterial infections, and also achieves beneficial effects such as enhancing host-directed antibacterial immunity, reducing toxic side effects, and minimizing potential drug resistance.